Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-01-11
2011-01-11
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S523000
Reexamination Certificate
active
07867997
ABSTRACT:
A δ-crystalline form of ivabradine hydrochloride of formula (I):characterised by its powder X-ray diffraction data.Medicinal products containing the same which are useful as bradycardics.
REFERENCES:
patent: 5296482 (1994-03-01), Peglion et al.
patent: 2005/0228177 (2005-10-01), Lerestif et al.
patent: 0543859 (1993-03-01), None
patent: 2868777 (2005-10-01), None
“Ivabradine Hydrochloride Antianginal HCN (LF Current) Blocker”, Drugs of the Future, p. 652-658, 2003.
French Preliminary Search Report for FR0510352 of Jun. 26, 2006.
Ferrari, et al.,European Heart Journal Supplements, 2005, 7 (Supplement H), H16-H21.
Fox,European Heart Journal Supplements, 2005, 7 (Supplement H), H33-H36.
Auguste Marie-Noelle
Damien Gerard
Horvath Stephane
Hueschen and Sage
Kifle Bruck
Les Laboratoires Servier
LandOfFree
δ-crystalline form of ivabradine hydrochloride, a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with δ-crystalline form of ivabradine hydrochloride, a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and δ-crystalline form of ivabradine hydrochloride, a... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2714944